Authors
Loading...
Retrospective study finds oral azacitidine maintenance improves outcomes in favorable-risk AML, suggesting MRD monitoring implications.
Hurvitz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: